Spleen News and Research

RSS
Incyte receives FDA approval for Jakafi to treat intermediate or high-risk MF

Incyte receives FDA approval for Jakafi to treat intermediate or high-risk MF

Four-year kala azar treatment study launched in India, Bangladesh

Four-year kala azar treatment study launched in India, Bangladesh

Infinity third quarter total revenue increases marginally to $23.3 million

Infinity third quarter total revenue increases marginally to $23.3 million

Viagra may improve antitumor immunity in people with melanoma

Viagra may improve antitumor immunity in people with melanoma

Largest-ever implementation study on kala-azar in Asia

Largest-ever implementation study on kala-azar in Asia

Earthquakes devastating in more ways than one: Review

Earthquakes devastating in more ways than one: Review

Beneficial intestinal bacteria can activate immune cells and trigger MS

Beneficial intestinal bacteria can activate immune cells and trigger MS

CryoLife begins enrollment in BioFoam Surgical Matrix IDE clinical trial

CryoLife begins enrollment in BioFoam Surgical Matrix IDE clinical trial

New metabolic pathway for controlling brain inflammation

New metabolic pathway for controlling brain inflammation

Researchers identify 'programmed cell death' pathway in parasitic worms

Researchers identify 'programmed cell death' pathway in parasitic worms

YM BioSciences begins enrollment in CYT387 Phase II trial for myelofibrosis

YM BioSciences begins enrollment in CYT387 Phase II trial for myelofibrosis

Sodium Stibogluconate & Paromomycin combination treatment for Kala azar

Sodium Stibogluconate & Paromomycin combination treatment for Kala azar

Scientists discover how liver destroys immune T-cells

Scientists discover how liver destroys immune T-cells

New insight into how nervous system regulates immunity

New insight into how nervous system regulates immunity

Memphis operation successfully separates twins joined at the spine

Memphis operation successfully separates twins joined at the spine

Researchers discover protein signals responsible for preserving anti-viral antibodies

Researchers discover protein signals responsible for preserving anti-viral antibodies

CD8 alpha+ dendritic cells can help the body beat back infection

CD8 alpha+ dendritic cells can help the body beat back infection

Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL

Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL

Researchers discover novel combination of two mutations in a patient with ADHD

Researchers discover novel combination of two mutations in a patient with ADHD

Chaos in biochemical alterations of cancer cells

Chaos in biochemical alterations of cancer cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.